De novo emergence of growth factor receptors in activated human CD4+ and CD8+ T lymphocytes

Metabolism: Clinical and Experimental

Volumn 53, Issue 1, 2004, Pages 117-122

  Stentz, Frankie B ^a   Kitabchi, Abbas E ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CYCLOHEXIMIDE; CYTOKINE; DACTINOMYCIN; GROWTH FACTOR RECEPTOR; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 2; MESSENGER RNA; PHYTOHEMAGGLUTININ; SOMATOMEDIN C;

ARTICLE; CELL MEMBRANE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; DRUG INHIBITION; DRUG SENSITIVITY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INSULIN BINDING; INSULIN LIKE ACTIVITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0346685840     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.07.015     Document Type: Article

References (32)

1. Accili D, Kanno H: The mechanism of insulin action. in Kahn CR, (ed): Atlas of Clinical Endocrinology and Diabetes, vol 2. Philadelphia, PA, Current Med, 1999, pp 12-28
2. Cheatham B, Kahn CR: The biochemistry of insulin action in LeRoith D, Taylor SI, Olefsky JM (eds): Diabetes Mellitus: A Fundamental and Clinical Text. Philadelphia, PA, Lippincott-Raven, 1996, pp 139-147
3. DeFronzo RA, Ferrannini E: Insulin resistance, a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1996
4. Saltiel AR, Kahn CR: Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414:799-806, 2001
5. Modan-Moses D, Janicot M, McLenithan JC, et al: Expression and function of insulin/insulin-like growth factor I hybrid receptors during differentiation of 3T3-L1 preadipocytes. Biochem J 333:825-831, 1998
6. White M, Fisher T: Mechanism of insulin action. in Skyler JS, (ed): Atlas of Diabetes. Philadelphia, PA, Lippincott Williams & Williams, 2002, pp 15-26
7. Stentz FB, Kitabchi AE, Schilling J, et al: Identification of insulin intermediates and sites of cleavage of native insulin (non-radioactive) by insulin protease from human fibroblasts. J Biol Chem 264:20275-20290, 1989
8. Howard BV, Mott DM, Fields RM, et al: Insulin stimulation of glucose entry in cultured human fibroblasts. J Cell Physiol 101:129-138, 1979
9. Buffington CK, Stentz FB, Kitabchi AE: Activation of pyruvate dehydrogenase complex by porcine and biosynthetic human insulin in cultured human fibroblasts. Diabetes 33:681-685, 1984
10. Buffington CK, El-Sheikh T, Matteri R, et al: Phytohemagglutinin (PHA) activated human T-lymphocytes: Insulin binding in T-lymphocytes. Biochem Biophys Res Commun 134:412-419, 1986
11. Helderman JH: Role of insulin in the intermediary metabolism of the activated thymic-derived lymphocyte. J Clin Invest 67:636-1642, 1981
12. Ercolani L, Lin HL, Ginsberg BH: Insulin-induced desensitization at the receptor and postreceptor level in mitogen-activated T-lymphocytes. Diabetes 34:931-937, 1985
13. Brown TJ, Ercolani L, Ginsberg BH: Properties and regulation of the T-lymphocyte receptor. J Recept Res 3:481-494, 1983
14. Stentz FB, Buffington CK, Seyer J, et al: Stimulated T-lymphocytes internalize and degrade insulin similar to other insulin target cells. Clin Res 38:34, 1990 (abstr)
15. Stentz FB, Buffington CK, Kitabchi AE, et al: Modulation of T-lymphocytes (CD2) action by insulin intermediates. Diabetes 40:982, 1991 (abstr)
16. Smith KA: Cell growth signal transduction is quantal. Ann NY Acad. Sci 766:263-271, 1995
17. Buffington CK, Givens JR, Kitabchi AE: Sensitivity of pyruvate dehydrogenase to insulin in activated T lymphocytes: Lack of responsiveness to insulin in patients with polycystic ovarian disease and diabetes. Diabetes 39:361-368, 1990
18. Stentz F, Tolley E, Headley S, et al: Mechanisms of NF-κB and glucocorticoid receptor (GR-α) in activation and regulation of systemic inflammation (SI) in ARDS. Am J Respir Crit Care Med 163:450, 2001 (abstr)
19. Meduri U, Tolley E, Chrousos G, et al: Prolonged methylprednisolone treatment supresses systemic inflammation in patients with unresolving ARDS. Am J Respir Crit Care Med 165:983-991, 2002
20. Runyan N, Stentz F, Meduri U, et al: Flow cytometric quantification of NF-κB and GR-α in TNF-α stimulated human granulocytes. J Invest Med 48:123, 2000 (abstr)
21. Stentz FB, Harris HL, Kitabchi AE: Characterization of insulin-degrading activity in intact and subcellular components of human fibroblasts. Endocrinology 116:926-934, 1985
22. Helderman JH: The insulin receptor on activated immunocompetent cells. Exp Gerontol 28:323-327, 1993
23. Stentz FB, Buffington CK, El-Sheikh T, et al: Pyruvate dehydrogenase (PDH) activation and insulin processing in stimulated T-lymphocytes. Diabetes 36:153, 1987 (abstr)
24. Casson P, Anderson RN, Herrod HG, et al: Oral dehydroepiandrosterone (DHEA) in physiologic doses modulates immune function in postmenopausal women. Am J Obstet Gynecol 169:1536-1539, 1993
25. Casson P, Faquin LC, Stentz FB, et al: Replacement of dehydroepiandrosterone (DHEA) enhances T-lymphocyte insulin binding in postmenopausal women. Fertil Steril 63:1027-1031, 1995
26. Spanheimer RG, Bar RS, Ginsberg BH, et al: Comparison of insulin binding to cells to fed and fasted obese patients: Results in erythrocytes and monocytes. J Clin Endocrinol Metab 54:40-47, 1982
27. Duckworth WC, Bennett RG, Hamel FG: Insulin degradation: Progress and potential. Endocr Rev 19:608-624, 1998
28. Mathis D, Vence L, Beroist C: B-cell death during progression to diabetes. Nature 414:792-798, 2001
29. Hoffman WH, Helman SW, Passmore G: Acute activation of peripheral lymphocytes during treatment of diabetic ketoacidosis. J Diabetes Complications 15:144-149, 2001
30. Umpierrez G., Culbreath B, Crisler J, et al: Cytokine response in patients with diabetic ketoacidosis. J Invest Med 50:141A, 2002 (abstr)
31. Loftus TM, Kuhajda FP, Lane MD: Insulin depletion leads to adipose-specific cell death in obese but not lean mice. Proc Natl Acad Sci USA 95:14168-14172, 1998
32. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001